Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Korro’s $116m Series B Round Will Advance Pipeline Beyond AATP

Jan 05 2022

• By Joseph Haas

Macro photo of tooth wheel mechanism with FUNDING concept words — RNA-editing focused Korro adds $116m to its prior $90m raise

Related Content

Vertex Suffers Setback In Its Search For Post-CF Blockbusters

Oct 15 2020

Finance Watch: 3Q Biopharma Venture Capital Financings Fell From 2Q Spike

Oct 10 2019

Finance Watch: $320m In New VC Deals Includes $110m Round For Neogene

Sep 15 2020

Semglee's Boost On Express Scripts Formulary Reflects Interchangeability – And Rebates

Oct 20 2021

It's Time For Novartis To Put Its Leqvio Launch Strategy To The Test

Dec 22 2021

Related Companies

Korro Bio, Inc.

CSL Limited

Vertex Pharmaceuticals Incorporated

Alnylam Pharmaceuticals Inc.

Ionis Pharmaceuticals, Inc.

Novartis AG

Additional Topics

Financing Business Strategies Platform Technologies Companies Innovation Rare Diseases Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window